tbuckley/cabot-search huggingface dataset:
RAPID CURE FOR APPENDICITIS.
Journal: JAMA (1899)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
A Manual of Dermatology.
Authors: None C. E. W.
Journal: JAMA (1884)

This admirable work commends itself to the student and practitioner by its clearness of style, its orderly arrangement, and its full and explicit directions respecting treatment. There is a marked resemblance among modern text-books of dermatology, and while this evidently belongs to the common species, it presents marked individual characteristics. The study of the cutaneous diseases affords an opportunity to follow the minute details of the morbid processes from the commencement of the attack until its termination in resolution or permanent lesion. The author has taken advantage of this opportunity and gives his readers an insight into the histology of many of the diseases considered. We sincerely hope that he will prosecute his plan of a more voluminous and criginal work, but, however necessary that may be to the specialist, we feel assured that the present publication will fully meet the needs of the general practitioner.
Hypertension Renal
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Diagnostic Chelation Challenge with DMSA: A Biomarker of Long-Term Mercury Exposure?
Authors: Howard Frumkin, Claudine C. Manning, Phillip L. Williams, Amanda Sanders, B. Brooks Taylor, Marsha Pierce, Lisa Elon, Vicki S. Hertzberg
Journal: Environmental Health Perspectives (2001)

Chelation challenge testing has been used to assess the body burden of various metals. The best-known example is EDTA challenge in lead-exposed individuals. This study assessed diagnostic chelation challenge with dimercaptosuccinic acid (DMSA) as a measure of mercury body burden among mercury-exposed workers. Former employees at a chloralkali plant, for whom detailed exposure histories were available (n = 119), and unexposed controls (n = 101) completed 24-hr urine collections before and after the administration of two doses of DMSA, 10 mg/kg. The urinary response to DMSA was measured as both the absolute change and the relative change in mercury excretion. The average 24-hr mercury excretion was 4.3 microg/24 hr before chelation, and 7.8 microg/24 hr after chelation. There was no association between past occupational mercury exposure and the urinary excretion of mercury either before or after DMSA administration. There was also no association between urinary mercury excretion and the number of dental amalgam surfaces, in contrast to recent published results. We believe the most likely reason that DMSA chelation challenge failed to reflect past mercury exposure was the elapsed time (several years) since the exposure had ended. These results provide normative values for urinary mercury excretion both before and after DMSA challenge, and suggest that DMSA chelation challenge is not useful as a biomarker of past mercury exposure.
Small Nucleolar RNA Expression Profiling Identifies Potential Prognostic Markers in Peripheral T-Cell Lymphoma.
Authors: Loic Ysebaert, Wilfried Valleron, Laure Berquet, Virginie Fataccioli, Cathy Quelen, Antoine Martin, Marie Parrens, Laurence Lamant, Laurence de Leval, Christian Gisselbrecht, Philippe Gaulard, Pierre Brousset
Journal: Blood (2012)
Health and Exercise for Girls.
Journal: JAMA (1928)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Sex and Gender Bias in Illustrations in Anatomy and Physical Diagnosis Texts
Authors: Kenneth A. Hubel
Journal: JAMA (1995)

<h3>To the Editor.</h3> —I read with interest the concerns of Ms Mendelsohn and colleagues<sup>1</sup>about sex and gender bias in anatomy and physical diagnosis text illustration. The article awakened my sense of injustice to the lingering influences of the waning patriarchy. I passed the article to several colleagues who then realized that their body types had not been represented among the standard anatomy configurations. One, in particular, weighs 370 pounds, and another from Taiwan noted that he could never recall having seen an epicanthal fold depicted in illustrations in Western anatomy textbooks. Having my awareness raised that anatomy illustrations have the power to "create the perception that the male body is 'normal' and the female body 'abnormal,'" I became concerned as a senior citizen that only bodies of the young were depicted. In the absence of illustrations of potbellies and sagging buttocks, would physicians now in training regard my
Heart Donor
Authors: Reetika Vazirani
Journal: JAMA (1992)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Use of Biological Markers and Pharmacokinetics in Human Health Risk Assessment
Authors: Dale Hattis
Journal: Environmental Health Perspectives (1991)

There are two reasons to connect discussions ofbiolo a markers and phacokinetics.irst, both tend to open up the black box between exposure and effect.Doing thi promisesmorecomplete nding than simple input- output analysis, the possibility of better mechanim-based projection of risk beyond the range of possible direct obser- vations, and the possibility ofgreater sensitivity ofanalysis, in some cases going from the or to the cell as the unit ofanalysis.Second, pharmacokinetic (or simlnar pharmacodynamic) analysis will often be essential for appropriate interpretation of biologia marker information.One needs some sort of dynamic model ofthe generation and loss of the marker in relation to exposure in order to use a biological marker, either to form a better measure of dosage (either ac- cumulated past dose, or biologically relevant dose), or to make an improved predition of effect. (For eample, the use ofa blood c level alone to pdit kidney effects might beinfrior to e ns based on pastaccumutionof uminthe kidny, based on the pt history ofc I blod leve x time).Several eamples wi be d of the use of biomarkers and pharmacokinetics in risk assessments for both carcinogenesis and other effects.
Noninvasive Cardiac Diagnosis
Authors: Alfred F. Parisi, Donald E. Tow, W. Robert Felix, Arthur A. Sasahara
Journal: New England Journal of Medicine (1977)

The burgeoning appeal of noninvasive methods in the evaluation of patients with cardiovascular disorders is based not only on their diagnostic efficacy but also on their ease of application, ready repeatability, relative lack of expense and negligible patient risk. It is unfortunate that for these very reasons, some of these tests are at times indiscriminately used in place of a careful history and physical examination or in the hope of discerning lesions beyond the diagnostic capability of current noninvasive methods.This review will emphasize effective use of noninvasive diagnostic procedures by underscoring their merits and limitations in the evaluation of . . .
Clinical Practice Guidelines and Scientific Evidence
Authors: John Concato
Journal: JAMA (2009)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Iron nutrition and the fortification of food with iron
Authors: C. A. Finch
Journal: JAMA (1972)

At present, a high incidence of iron deficiency prevails in the infant and female population. Improvement in iron balance through fortification of food with additional iron is needed to prevent such deficiency. In the infant, this may be accomplished through the fortification of special food items whose use is confined to infancy. In the adult woman, an increase in fortification of flour and flour products to 40 mg/lb is proposed to accomplish this. Such manipulation of the public diet carries with it the responsibility of monitoring its effects on the iron balance of the population, and on the prevalence of iron deficiency and iron overload.
Mens Sana in Hemicorpore Sano
Journal: JAMA (1970)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Notice to Readers: International Standards for Tuberculosis Care and The Patients' Charter for Tuberculosis Care
Authors: J Stull, E Talbot, S Macrae, J Montero, New Hampshire, R Matyas, A Konomi, T Hayes, J Nasci, O Sejvar, G Leary, A Campbell, R Noga, S Plotinsky
Journal: JAMA (2006)

in four counties were EEEV positive.
Abstract 18189: Neointimal Response to Everolimus-eluting Bioresorbable Scaffolds Implanted at Bifurcating Coronary Segments: An Optical Coherence Tomography Study
Authors: Takao Sato, Mohamed Abdel-Wahab, Mohamed El-Mawardy, Ralph Tölg, Gert Richardt
Journal: Circulation (2015)

Background: Previous studies have described different patterns of neointimal coverage between the outer wall and inner wall at coronary bifurcations lesions (BL) treated with metallic drug-eluting stents (DES) due to endothelial shear stress. Everolimus-eluting bioresorbable scaffolds (BRS) have thicker struts and could therefore have a stronger influence on endothelial shear stress compared to DES. However, the neointimal coverage of BL treated with BRS has not been adequately studied. We sought to evaluate the vascular response to BRS struts deployed at BL using optical coherence tomography (OCT). Methods: 50 patients (64 lesions) underwent follow-up OCT 11.0 ± 2.1 months after BRS implantation. Cross-sectional area of BL with a side branch more than 1mm using OCT was analyzed every 200μm. All images were divided into 3 regions according to shear stress: the 1/2 circumference of the vessel opposite to the ostium (OO), side branch ostium (SO), and the vessel wall adjacent to the ostium (AO). %uncovered strut of all struts and the averaged neointimal thickness (NIT) in 3 regions were evaluated. Additionally, to assess the impact of the side branch size on neointimal proliferation in BL, we calculated the ratio of the diameter of side branch ostium (Ds) to the diameter of main branch (Dm) (Ds/Dm) and divided patients into two groups based on median value of Ds/Dm of 0.318 as follow: large ratio side branch group (LRSB, n=32) and small ratio side branch group (SRSB, n=32). Results: Mean BRS diameter and length were 3.01±0.37 and 20.7±5.5mm. Mean diameter of all side branches was 1.69±0.51mm. In all patients, there was a significant difference in NIT among 3 regions (OO, 121±66 vs. AO, 96±32 vs. SO, 82±43μm, p=0.03). A significant difference was shown in %uncovered strut among 3 regions (OO, 0.45 vs. AO, 1.5 vs. SO, 4.7%, p=0.03). Further, in LRSB group, there was a significant difference in NIT among 3 regions (OO, 130±63 vs. AO, 92±38 vs. SO, 75±39 μm, p=0.01), and a significant difference was shown in %uncovered strut among 3 regions (OO, 0.37 vs. AO, 2.0 vs. SO, 8.8%, p=0.01). Conclusion: Different patterns of neointimal coverage are observed between the outer wall and inner wall of BL treated with BRS. Neointimal coverage is least at and adjacent to large side branches.
Adverse Drug Reactions
Authors: William R. Barclay
Journal: JAMA (1979)

For many years the American Medical Association maintained a file of adverse drug reactions voluntarily reported by physicians. The Association discontinued this activity because most physicians were reluctant to report suspect reactions or would file a report with insufficient supporting data. The AMA finally closed out its file on adverse drug reactions and transferred responsibility for future monitoring to the Food and Drug Administration. This is unfortunate, for evaluation of medical risks and hazards would be better left in the private sector than being placed with a government regulatory agency. Many factors discourage physicians from reporting adverse drug reactions, but one of the most important is uncertainty about whether an observed reaction is actually caused by a drug. This uncertainty generally results in underreporting; however, some studies conducted through retrospective chart reviews have given a false impression of the magnitude of the problem by including reactions unrelated to administered drugs.
Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages
Authors: Sushil Kumar Pathak, Sanchita Basu, Kunal Kumar Basu, Anirban Banerjee, Shresh Pathak, Asima Bhattacharyya, Tsuneyasu Kaisho, Manikuntala Kundu, Joyoti Basu
Journal: Nature Immunology (2007)
FOREIGN CORRESPONDENCE.
Authors: None G. O. M.
Journal: JAMA (1884)

London, April, 1884. Before long, the stronger sex will have to meet the gentler on an equal footing in all the professions. The invasion of women, which is the chief event in recent university history, has advanced another step at Oxford, when congregation agreed by 100 votes against 46 to admit women to several university examinations. The girls will not yet, at least, be examined in the new schools with the undergraduates, but they will have the same papers and the same examiners, and their class lists will be drawn up on the same standard. The lady students at Cambridge have been for some time examined in this way. The opponents of the scheme, however, were divided amongst themselves; some of them arguing that as women were so notoriously inferior to men it would be unkind to subject them to the same examinations, whilst others thought that the change would
GMC's professional conduct committee
Journal: BMJ (1983)

committees about the dispersal of vacant medical practices, the GMSC should look at the effect of delays in decisions being reached on such issues, and seek guidance from the DHSS on what is 'sufficient time' for consultation and how long an appeal by a community health council to the Secretary of State might take."The committee decided, as a matter of urgency, to look at the whole question of family practitioner commlittee consultation with community health councils.
PREANESTHETIC MEDICATION
Authors: Philip D. Woodbridge
Journal: JAMA (1960)

<h3>To the Editor:—</h3> Satisfactory preanesthetic sedation from the almost routine use of promethazine with either scopolamine or atropine was reported by Dr. George Wallace inThe Journal, June 18, page 797. He shares the "belief that narcotics should not be used for preanesthetic medication except in the presence of the major indication for such agents—pain." Presumably he referred to pain existing before operation. I agree that drugs should be used only for definite indications and that we should hesitate to use a drug that is mainly a pain reliever unless pain is present. However, there are at least two other factors which one should take into account before deciding to avoid narcotics preoperatively: (1) practically every surgical operation involves pain, and (2) narcotics produce desirable sedation and, in some instances, drying of mucous membranes as well as relief from pain. I have previously pointed out (<i>Anesthesiology</i><b>18:</b>536 [July-Aug.] 1957)
Chemotherapy for bronchogenic carcinoma. Methotrexate, doxorubicin, cyclophosphamide, and lomustine
Authors: P. A. Chahinian
Journal: JAMA (1977)

A combination chemotherapy (MACC) consisting of methotrexate, doxorubicin hydrochloride (Adriamycin), cyclophosphamide, and lomustine (CCNU) was given to 41 patients with stage III bronchogenic carcinoma, 34 of whom had disseminated disease. The objective response rate was 46% for all patients with a median actuarial survival of nine months. Response was seen in all cell types, including four of ten patients with squamous cell carcinoma, six of 17 with adenocarcinoma, and six of seven with small-cell anaplastic carcinoma. Prolongation of survival was apparent for patients of all cell types. Toxic reactions were moderate and allowed for easy outpatient use. (<i>JAMA</i>237:2392-2396, 1977)